An efficient, non-viral arrayed CRISPR screening platform for iPSC-derived myeloid and microglia models

Authors:
Meier S, Larsen ASG, Wanke F, Mercado N, Mei A, Takacs L, Mracsko ES, Collin L, Kampmann M, Roudnicky F, Jagasia R
In:
Source: Stem Cell Reports
Publication Date: (2025)
Issue: 20(3): 102420
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Stem Cells
Gene Expression
Basic Research
Molecular Biology
Respiratory Research
Regenerative medicine
Cells used in publication:
Macrophage, human
Species: human
Tissue Origin: blood
Induced Pluripotent Stem Cell (iPS), human
Species: human
Tissue Origin:
Culture Media:
Platform:
4D-Nucleofector® 96-well Systems
Experiment

preMac differentiation into microglia and macrophages
For microglia differentiation, preMacs were seeded on fibronectin- coated plates (Corning) in DMEM/F12 + GlutaMAX supplied with N2 supplement (Gibco) and containing human recombinant M-CSF (25 ng/mL), IL-34 (100 ng/mL; Miltenyi Biotec), and transforming growth factor b1 (50 ng/mL; PreproTech). 50% medium was changed every second day for 10 days. Conversely, macrophages were initially cultured without coating in X-VIVO15 medium or ImmunoCult for macrophage differentiation (STEMCELL Technologies) containing 100 ng/mL M-CSF for 6 days, with a 50% medium change on day 3. For nucleofection, macrophages were differentiated in RPMI 1640 with 10% FCS (Gibco) containing M-CSF (100 ng/mL) instead for 6 days.

Optimized nucleofection protocol for preMacs with subsequent microglia differentiation
25 pmol of sgRNA was complexed with 2 µg of TrueCut Cas9 protein v2 (Invitrogen) for 20 min at room temperature. 50,000 preMacs per reaction were resuspended in
20 µL P3 Primary Cell Nucleofector solution (Lonza) and mixed with CRISPR-Cas9 RNPs before nucleofection with CM-137 pulse code using a 4D-Nucleofector 96-well
Shuttle nucleofector (Lonza). After nucleofection, cells were allowed to rest for 5 min before 80 µL microglia differentiation medium (see earlier text) was added per well and suspension was transferred to a fibronectin-coated seeding plate (PhenoPlate, PerkinElmer) containing 100 µL differentiation medium. 75% of the medium was changed the day post-nucleofection, and then 50% medium changes were carried out every two days.

Abstract

Here, we developed a CRISPR-Cas9 arrayed screen to investigate lipid handling pathways in human induced pluripotent stem cell (iPSC)- derived microglia.We established a robust method for the nucleofection of CRISPR-Cas9 ribonucleoprotein complexes into iPSC-derived myeloid cells, enabling genetic perturbations. Using this approach, we performed a targeted screen to identify key regulators of lipid droplet formation dependent on Apolipoprotein E (APOE). We identify the Mammalian Target of Rapamycin Complex 1 (mTORC1) signaling pathway as a critical modulator of lipid storage in both APOE3 and APOE knockout microglia. This study is a proof of concept underscoring the utility of CRISPR-Cas9 technology in elucidating the molecular pathways of lipid dysregulation associated with Alzheimer’s disease and neuroinflammation.